Girish Venkatachaliah - Apr 14, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Technology Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Apr 14, 2023
Transactions value $
-$38,620
Form type
4
Date filed
4/18/2023, 04:51 PM
Previous filing
Sep 29, 2022
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +22K +139.04% $0.00 37.8K Apr 14, 2023 Direct F1, F2, F3
transaction AGL Common Stock Tax liability -$38.6K -1.36K -3.59% $28.46 36.4K Apr 14, 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +38K $0.00 38K Apr 14, 2023 Common Stock 38K $28.46 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2 Includes restricted stock units.
F3 The total was decreased by 476 shares as reported in the Form 4 Amendment filed on September 29, 2022.
F4 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F5 Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

Remarks:

Exhibit List: Ex.24 - Power of Attorney